基于脂质纳米粒子输送系统的个性化膜蛋白疫苗可以在结直肠癌模型中预防术后复发

Guangzhao Shi1, Yuandong Xu2, Haowei Qiu2

  • 1Department: Digestive Medicine Centre, Guangdong Provincial Key Laboratory of Digestive Cancer Research, Institution: The Seventh Affiliated Hospital Sun Yat-sen University, No.628, Zhenyuan Road, Guangming District, Shenzhen, Guangdong CN518107, PR China.

Acta biomaterialia
|December 5, 2024
PubMed
概括

这项研究开发了一种使用脂质纳米粒子 (LNP) 和瘤抗原的个性化癌症疫苗. 该疫苗显示出强大的抗瘤作用,诱导免疫记忆,并显示出临床癌症治疗的前景.